For: | Li TT, Liu H, Li FP, Hu YF, Mou TY, Lin T, Yu J, Zheng L, Li GX. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response. World J Gastroenterol 2015; 21(47): 13259-13267 [PMID: 26715808 DOI: 10.3748/wjg.v21.i47.13259] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i47/13259.htm |
Number | Citing Articles |
1 |
Alexandra Kölbl, Udo Jeschke, Ulrich Andergassen. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells. International Journal of Molecular Sciences 2016; 17(8): 1308 doi: 10.3390/ijms17081308
|
2 |
Xiao-Xiang Jie, Xiao-Yan Zhang, Cong-Jian Xu. Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications. Oncotarget 2017; 8(46): 81558 doi: 10.18632/oncotarget.18277
|
3 |
Chengguang Yang, Wenfang Zhuang, Yuemei Hu, Leiming Zhu. Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-017-1305-2
|
4 |
Ting-Ting Li, Hao Liu, Jiang Yu, Guang-Yao Shi, Li-Ying Zhao, Guo-Xin Li. Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells. World Journal of Gastroenterology 2018; 24(21): 2236-2246 doi: 10.3748/wjg.v24.i21.2236
|
5 |
Lu-Nan Qi, Bang-De Xiang, Fei-Xiang Wu, Jia-Zhou Ye, Jian-Hong Zhong, Yan-Yan Wang, Yuan-Yuan Chen, Zu-Shun Chen, Liang Ma, Jie Chen, Wen-Feng Gong, Ze-Guang Han, Yan Lu, Jin-Jie Shang, Le-Qun Li. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Research 2018; 78(16): 4731 doi: 10.1158/0008-5472.CAN-17-2459
|
6 |
Jing Chen, Shun-Wang Cao, Zhen Cai, Lei Zheng, Qian Wang. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients. Cancer Biomarkers 2017; 20(4): 487 doi: 10.3233/CBM-170315
|
7 |
Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/5188006
|
8 |
Yaopeng Qiu, Xinxin Zhang, Xiangqian Deng, Renyi Zhang, Zhen Cai, Zhenzhan Zhang, Hao Liu. Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy. European Journal of Surgical Oncology 2022; 48(5): 1039 doi: 10.1016/j.ejso.2021.11.115
|
9 |
Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Keishi Okubo, Takashi Kijima, Daisuke Matsushita, Masahiko Amatatsu, Hiroshi Kurahara, Kosei Maemura, Shoji Natsugoe. Clinical significance of circulating tumor cells in blood from patients with gastric cancer. Annals of Gastroenterological Surgery 2017; 1(1): 60 doi: 10.1002/ags3.12005
|
10 |
Yongrong Lei, Xishu Wang, Heng Sun, Yuna Fu, Yichen Tian, Ludi Yang, Jianhua Wang, Feng Xia. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.601668
|
11 |
Shalong Wang, Lianwen Yuan. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine. BioScience Trends 2016; 10(3): 171 doi: 10.5582/bst.2016.01078
|
12 |
Jacqueline Aparecida Torres, Victor Hugo Fonseca de Jesus. Atlas of Liquid Biopsy. 2021; : 103 doi: 10.1007/978-3-030-69879-9_7
|
13 |
Shoujie Chai, Carmen Ruiz-Velasco, Amin Naghdloo, Milind Pore, Mohan Singh, Nicholas Matsumoto, Anand Kolatkar, Liya Xu, Stephanie Shishido, Ana Aparicio, Amado J. Zurita, James Hicks, Peter Kuhn. Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case. npj Precision Oncology 2022; 6(1) doi: 10.1038/s41698-022-00289-1
|
14 |
Huajian Peng, Xiang Tan, Yongyong Wang, Lei Dai, Guanbiao Liang, Jianji Guo, Mingwu Chen. <p>Clinical Significance of Red Cell Distribution Width and Circulating Tumor Cells with an Epithelial–Mesenchymal Transition Phenotype in Lung Adenocarcinoma</p>. Cancer Management and Research 2020; : 5105 doi: 10.2147/CMAR.S251271
|
15 |
Minghui Li, Yajie Lu, Zuoyao Long, Mengyang Li, Jing Kong, Guojing Chen, Zhen Wang. Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma. Journal of Bone Oncology 2019; 16: 100236 doi: 10.1016/j.jbo.2019.100236
|
16 |
Yunjie Yang, Zheng Liu, Qifeng Wang, Kun Chang, Junyu Zhang, Dingwei Ye, Yunyi Kong, Bo Dai. Presence of CD133‐positive circulating tumor cells predicts worse progression‐free survival in patients with metastatic castration‐sensitive prostate cancer. International Journal of Urology 2022; 29(5): 383 doi: 10.1111/iju.14801
|
17 |
Zhong Wang, Lei Luo, Yuan Cheng, Guolin He, Bangjian Peng, Yi Gao, Ze-sheng Jiang, MingXin Pan. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood. Journal of Gastrointestinal Surgery 2018; 22(4): 633 doi: 10.1007/s11605-017-3619-3
|
18 |
YongRong Lei, XiShu Wang, YiChen Tian, Rong Xu, Jun Pei, YuNa Fu, Heng Sun, YaNi Wang, Ping Zheng, Feng Xia, JianHua Wang. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1209403
|
19 |
Yuan Cheng, Lei Luo, Juqiang Zhang, Mantian Zhou, Yujun Tang, Guolin He, Yishi Lu, Zhong Wang, MingXin Pan. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2019; 23(12): 2354 doi: 10.1007/s11605-018-04067-y
|
20 |
Fengjie Wu, Jun Zhu, Yongjiang Mao, Xiaomei Li, Baoguang Hu, Dianliang Zhang. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/9474532
|
21 |
Adriana Carneiro, Paulina Piairo, Alexandra Teixeira, Dylan Ferreira, Sofia Cotton, Carolina Rodrigues, Alexandre Chícharo, Sara Abalde-Cela, Lúcio Lara Santos, Luís Lima, Lorena Diéguez. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients. Cells 2022; 11(3): 376 doi: 10.3390/cells11030376
|
22 |
Takahiro Okabe, Shinsaku Togo, Yuichi Fujimoto, Junko Watanabe, Issei Sumiyoshi, Akira Orimo, Kazuhisa Takahashi. Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers 2020; 12(12): 3588 doi: 10.3390/cancers12123588
|
23 |
Jing Chen, Shunwang Cao, Bo Situ, Juan Zhong, Yanwei Hu, Shufen Li, Jinlan Huang, Jiasen Xu, Shiyang Wu, Jinduan Lin, Qianwen Zhao, Zhen Cai, Lei Zheng, Qian Wang. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0789-0
|
24 |
Qian Zhang, Wanting Xing, Jie Zhang, Junwen Hu, Lunan Qi, Bangde Xiang. Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma. OncoTargets and Therapy 2021; : 1543 doi: 10.2147/OTT.S298576
|
25 |
Deyu Li, Na Li, Ying Ding. Epithelial‑to‑mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients. Molecular and Clinical Oncology 2022; 17(3) doi: 10.3892/mco.2022.2574
|
26 |
Catherine Alix-Panabières, Sonja Mader, Klaus Pantel. Epithelial-mesenchymal plasticity in circulating tumor cells. Journal of Molecular Medicine 2017; 95(2): 133 doi: 10.1007/s00109-016-1500-6
|
27 |
Yun‐Jie Yang, Yun‐Yi Kong, Gao‐Xiang Li, Yue Wang, Ding‐Wei Ye, Bo Dai. Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration‐sensitive prostate cancer. BJU International 2019; 124(2): 258 doi: 10.1111/bju.14642
|
28 |
Hailong Liu, Jie Ding, Yanyuan Wu, Di Wu, Jun Qi. <p>Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer</p>. Cancer Management and Research 2020; : 4549 doi: 10.2147/CMAR.S253997
|
29 |
Yasi Xing, Xinfa Zhang, Fangyuan Qin, Jingwen Yang, Lei Ai, Qingsong Wang, Yaping Zhai. The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. Bioengineered 2022; 13(2): 2128 doi: 10.1080/21655979.2021.2023800
|
30 |
P. Zhang, H. Zhou, K. Lu, Y. Wang, T. Feng. Circulating tumor cells in the clinical cancer diagnosis. Clinical and Translational Oncology 2020; 22(3): 279 doi: 10.1007/s12094-019-02139-2
|
31 |
Baoguang Hu, Xiaokun Tian, Yanbin Li, Yangchun Liu, Tao Yang, Zhaodong Han, Jiajia An, Lingqun Kong, Yuming Li. Epithelial‐mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1. Cancer Medicine 2020; 9(8): 2686 doi: 10.1002/cam4.2871
|
32 |
Joon Hyung Jhi, Gwang Ha Kim, Su Jin Park, Dong Uk Kim, Moon Won Lee, Bong Eun Lee, Chae Hwa Kwon, Yoon-Kyoung Cho. Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study. Journal of Clinical Medicine 2021; 10(19): 4481 doi: 10.3390/jcm10194481
|
33 |
Aravind Sanjeevaiah, Haeseong Park, Benjamin Fangman, Matthew Porembka. Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches. Cancers 2020; 12(3): 592 doi: 10.3390/cancers12030592
|
34 |
Richard A. Jacobson, Emily Munding, Dana M. Hayden, Mia Levy, Timothy M. Kuzel, Sam G. Pappas, Ashiq Masood. Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers. Cancers 2019; 11(8): 1164 doi: 10.3390/cancers11081164
|
35 |
Kun Zou, Shuailong Yang, Liang Zheng, Shuyi Wang, Bin Xiong. Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/2765464
|
36 |
Qingming Xie, Shilei Liu, Sai Zhang, Liqiu Liao, Zhi Xiao, Shouman Wang, Pengfei Zhang. Research progress on the multi-omics and survival status of circulating tumor cells. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01309-z
|
37 |
Jingyao Li, Yi Liao, Yaling Ran, Guiyu Wang, Wei Wu, Yang Qiu, Jie Liu, Ningyu Wen, Tao Jing, Haidong Wang, Shixin Zhang. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer. BMC Pulmonary Medicine 2020; 20(1) doi: 10.1186/s12890-020-01314-4
|
38 |
Zhenlong Wang, Peng Zhang, Yue Chong, Yuquan Xue, Xiaojie Yang, Hecheng Li, Li Wang, Yaping Zhang, Qi Chen, Zhaolun Li, Li Xue, HongLiang Li, Tie Chong, Chiara Nicolazzo. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/9956142
|
39 |
Riley D.Z. Mullins, Ananya Pal, Thomas F. Barrett, Molly E. Heft Neal, Sidharth V. Puram. Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Research 2022; 82(13): 2329 doi: 10.1158/0008-5472.CAN-21-4370
|
40 |
Heming Li, Yang-Zhuangzhuang Zhu, Lu Xu, Tao Han, Jiasi Luan, Xin Li, Yuting Liu, Zhi Wang, Qiuge Liu, Xiangyu Kong, Chunpu Zou, Lin Su, Yifei Hou, Xiao Chen, Lujun Chen, Ruoyu Wang, Zihang Xu, Mingfang Zhao. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03043-6
|
41 |
Huiling Wang, Mian Lv, Yonghong Huang, Xiaoming Pan, Changyuan Wei. Identification of Circulating Tumor Cell Phenotype in Differentiated Thyroid Carcinoma. Journal of Biomaterials and Tissue Engineering 2022; 12(4): 813 doi: 10.1166/jbt.2022.2957
|
42 |
Qian Deng, Bo Jiang, Haijiao Yan, Jun Wu, Zhenzhen Cao. Circulating tumor cells in gastric cancer: developments and clinical applications. Clinical and Experimental Medicine 2023; 23(8): 4385 doi: 10.1007/s10238-023-01158-2
|
43 |
Marie‐Emilie Francart, Justine Lambert, Aline M. Vanwynsberghe, Erik W. Thompson, Morgane Bourcy, Myriam Polette, Christine Gilles. Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases. Developmental Dynamics 2018; 247(3): 432 doi: 10.1002/dvdy.24506
|
44 |
Yuchen Zhong, Tianyi Ma, Tianyu Qiao, Hanqing Hu, Zhengliang Li, Kangjia Luo, Yuliuming Wang, Qingchao Tang, Guiyu Wang, Rui Huang, Xishan Wang. Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer. Cancer Management and Research 2021; : 7077 doi: 10.2147/CMAR.S316544
|
45 |
Yifan Xu, Qianlong Zhang, Zhou Xu, Qingfeng Xie, Wenfu Ding, Hao Liu, Haijun Deng. Association of circulating tumor cell-white blood cell clusters with survival outcomes in patients with colorectal cancer after curative intent surgery. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02603-4
|
46 |
Hang-Hang Ni, Xi-Hua Yang, Cheng-Lei Yang, Qian Zhang, Jing-Xuan Xu, Lu-Nan Qi, Bang-De Xiang, Udayan Apte. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/7305953
|
47 |
Jitao Zhou, Xin Ma, Feng Bi, Ming Liu. Clinical significance of circulating tumor cells in gastric cancer patients. Oncotarget 2017; 8(15): 25713 doi: 10.18632/oncotarget.14879
|
48 |
Mārcis Leja, Aija Linē. Early detection of gastric cancer beyond endoscopy - new methods. Best Practice & Research Clinical Gastroenterology 2021; : 101731 doi: 10.1016/j.bpg.2021.101731
|
49 |
Mohammad Reza Eskandarion, Sharareh Eskandarieh, Sara Tutunchi, Abbas Shakoori Farahani, Reza Shirkoohi. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01310-6
|
50 |
Lin Song, Xin Zhou, Hong-Jun Jia, Mei Du, Jin-Ling Zhang, Liang Li. Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice. Asian Pacific Journal of Tropical Medicine 2016; 9(8): 796 doi: 10.1016/j.apjtm.2016.06.004
|
51 |
Yunyang Chen, Shaoming Li, Wei Li, Rongbing Yang, Xianguang Zhang, Yong Ye, Jiexiong Yu, Lin Ye, Wangrong Tang. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43572-1
|
52 |
Zihao Zhang, Hao Wu, Wei Chong, Liang Shang, Changqing Jing, Leping Li. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death & Disease 2022; 13(10) doi: 10.1038/s41419-022-05350-2
|
53 |
Xihua Yang, Hanghang Ni, Zhan Lu, Jie Zhang, Qian Zhang, Shangwu Ning, Lunan Qi, Bangde Xiang. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10503-3
|
54 |
Camila Tavares Uchôa Guimarães, Nina Nayara Ferreira Martins, Kelly Cristina da Silva Oliveira, Caroline Martins Almeida, Thayanne Macedo Pinheiro, Carolina Oliveira Gigek, Sandro Roberto de Araújo Cavallero, Paulo Pimentel Assumpção, Marília Arruda Cardoso Smith, Rommel Rodríguez Burbano, Danielle Queiroz Calcagno. Liquid biopsy provides new insights into gastric cancer. Oncotarget 2018; 9(19): 15144 doi: 10.18632/oncotarget.24540
|
55 |
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang, MingXin Pan. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Journal of Gastrointestinal Surgery 2021; 25(7): 1770 doi: 10.1007/s11605-020-04755-8
|
56 |
Giulia Gallerani, Tania Rossi, Manuela Ferracin, Massimiliano Bonafè. Circulating Tumor Cells, From Biotech Innovation to Clinical Utility. International Review of Cell and Molecular Biology 2023; 381: 99 doi: 10.1016/bs.ircmb.2023.07.004
|
57 |
Yang Li, Na Huang, Chunlin Wang, Huanrong Ma, Minyu Zhou, Li Lin, Zhenhua Huang, Li Sun, Min Shi, Wangjun Liao. Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells. Oncology Letters 2018; doi: 10.3892/ol.2018.9019
|
58 |
Yui Ishiguro, Hideyasu Sakihama, Tadashi Yoshida, Nobuki Ichikawa, Shigenori Homma, Moto Fukai, Hideki Kawamura, Norihiko Takahashi, Akinobu Taketomi. Prognostic Significance of Circulating Tumor Cells with Mesenchymal Phenotypes in Patients with Gastric Cancer: A Prospective Study. Annals of Surgical Oncology 2021; 28(2): 1178 doi: 10.1245/s10434-020-08827-6
|
59 |
Anthony Genna, Aline M. Vanwynsberghe, Amélie V. Villard, Charles Pottier, Julien Ancel, Myriam Polette, Christine Gilles. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers 2020; 12(6): 1632 doi: 10.3390/cancers12061632
|
60 |
Danfei Xu, Fengzhi Feng, Yuqing Pei, Yujuan Zhang, Yue Wu, Yi Guo, Wei Cui. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms. American Journal of Reproductive Immunology 2020; 83(5) doi: 10.1111/aji.13233
|